0001127602-11-017747.txt : 20110527 0001127602-11-017747.hdr.sgml : 20110527 20110527151336 ACCESSION NUMBER: 0001127602-11-017747 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110526 FILED AS OF DATE: 20110527 DATE AS OF CHANGE: 20110527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEAMING NANCY CENTRAL INDEX KEY: 0001265751 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 11878000 MAIL ADDRESS: STREET 1: C/O HOLOGIC INC STREET 2: 35 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN IDEC INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 133 BOSTON POST ROAD CITY: WESTON STATE: MA ZIP: 02493 BUSINESS PHONE: 7814642000 MAIL ADDRESS: STREET 1: 133 BOSTON POST ROAD CITY: WESTON STATE: MA ZIP: 02493 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2011-05-26 0000875045 BIOGEN IDEC INC. BIIB 0001265751 LEAMING NANCY BIOGEN IDEC INC. 133 BOSTON POST ROAD WESTON MA 02493 1 Common Stock 2011-05-26 4 M 0 25000 55.97 A 33820 D Common Stock 2011-05-26 4 M 0 2200 55.97 A 36020 D Common Stock 2011-05-26 4 M 0 5975 53.43 A 41995 D Common Stock 2011-05-26 4 S 0 28544 92.9827 D 13451 D Common Stock 2011-05-26 4 S 0 4631 93.4974 D 8820 D Stock Option (Right to Buy) 55.97 2011-05-26 4 M 0 25000 0 D 2018-01-08 Common Stock 25000 10000 D Stock Option (Right to Buy) 55.97 2011-05-26 4 M 0 2200 0 D 2009-01-08 2018-01-08 Common Stock 2200 0 D Stock Option (Right to Buy) 53.43 2011-05-26 4 M 0 5975 0 D 2010-06-03 2019-06-02 Common Stock 5975 0 D Exercise/Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. This represents the weighted average price for shares sold at a range between $92.41 (low) and $93.40 (high). Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer. This represents the weighted average price for shares sold at a range between $93.41 (low) and $93.60 (high). The stock options become exercisable in three (3) equal annual installments, commencing one year after the grant date of 01/08/2008. Options will become 100% exercisable upon completion of one year of service with Biogen Idec Inc. Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC Rule 16(b)-3(d). Aras Lapinskas, Attorney in Fact for Nancy L. Leaming 2011-05-27 EX-24 2 doc1.txt POWER OF ATTORNEY LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS Know all by these presents, that the undersigned hereby makes, constitutes and appoints Susan H. Alexander, Aras Lapinskas, Robert A. Licht, Robin A. Walker and Marcia J. Gookin as the undersigned's true and lawful attorney-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of the undersigned to: (1) prepare, execute in the undersigned?s name and on the undersigned?s behalf, and submit to the U.S. Securities and Exchange Commission (the ?SEC?) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC; (2) prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5 (including any amendments thereto) with respect to the securities of Biogen Idec Inc., a Delaware corporation (the "Company"), with the United States Securities and Exchange Commission, any national securities exchanges and the Company, as considered necessary or advisable under Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as amended from time to time (the "Exchange Act"); (3) seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information; and (4) perform any and all other acts which in the discretion of such attorney-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing. The undersigned acknowledges that: (1) this Limited Power of Attorney authorizes, but does not require, such attorney-in-fact to act in their discretion on information provided to such attorney-in-fact without independent verification of such information; (2) any documents prepared and/or executed by such attorney-in-fact on behalf of the undersigned pursuant to this Limited Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable; (3) neither the Company nor such attorney-in-fact assumes (i) any liability for the undersigned's responsibility to comply with the requirement of the Exchange Act, (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and (4) this Limited Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act. The undersigned hereby gives and grants the foregoing attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, hereby ratifying all that such attorney-in-fact of, for and on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney. This Limited Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to such attorney-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be executed as of this 11th day of January, 2011. _/s/ Nancy L. Leaming__ Signature Name: Nancy L. Leaming